SR
SFPIM Relaunch
SFPIM Relaunch is a Series A to growth stage investment firm. It has made 11 investments. Their most common stage is series-a (58% of deals).
Portfolio
11
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Fyteko | Series B | — | Jan 2025 |
 ATB Therapeutics | Series A | — | Nov 2024 |
 Blue Foot Membrane | Growth | — | Jan 2024 |
 Paleo | Series A | $12.7M | Feb 2023 |
 Magnax | Unknown | — | Jan 2022 |
| Magnax | Series A | — | Jan 2020 |
| SSYNERGIA MEDICAL | Series A | — | Feb 2018 |
 ITINERIS | Unknown | — | Jan 2017 |
 TangentWorks | Series A | — | — |
| PPaleo | Series A | — | — |
 EPICS THERAPEUTICS | Series A | — | — |
 NCARDIA BELGIUM | Series B | — | — |
Top Co-Investors
SFPIM4 shared
Gimv3 shared
Planet A2 shared
DSM Venturing2 shared
Beyond Impact2 shared
Siddhi Capital2 shared
Wallonie Entreprendre2 shared
Newton Biocapital2 shared
Saffelberg Investments1 shared
Force Over Mass Capital1 shared
dsm-firmenich Ventures1 shared
Fund+1 shared
Supernova Invest1 shared
Innovation Global Capital1 shared
EIT Food1 shared
Smartfin1 shared
Alychlo1 shared
Vesalius Biocapital1 shared
InnovationQuarter1 shared
Last updated: 19 September 2026